BMO Capital Maintains Outperform on National Health Investors, Lowers Price Target to $80
National Health Investors, Inc.
National Health Investors, Inc. NHI | 0.00 |
BMO Capital analyst Juan Sanabria maintains National Health Investors (NYSE:
NHI) with a Outperform and lowers the price target from $90 to $80.